UMMS Affiliation

Department of Molecular Genetics and Microbiology

Publication Date


Document Type



Animals; Antibody Diversity; DNA Primers; DNA-Binding Proteins; Immunoglobulin Class Switching; Immunoglobulin Switch Region; Mice; Mice, Knockout; *Models, Genetic; MutS Homolog 2 Protein; Polymerase Chain Reaction; Proto-Oncogene Proteins; Tandem Repeat Sequences


Life Sciences | Medicine and Health Sciences | Women's Studies


The mechanisms that target class switch recombination (CSR) to antibody gene switch (S) regions are unknown. Analyses of switch site locations in wild-type mice and in mice that lack the Smu tandem repeats show shifts indicating that a 4-5-kb DNA domain (bounded upstream by the Imu promoter) is accessible for switching independent of Smu sequences. This CSR-accessible domain is reminiscent of the promoter-defined domains that target somatic hypermutation. Within the 4-5-kb CSR domain, the targeting of S site locations also depends on the Msh2 mismatch repair protein because Msh2-deficient mice show an increased focus of sites to the Smu tandem repeat region. We propose that Msh2 affects S site location because sequences with few activation-induced cytidine deaminase targets generate mostly switch DNA cleavages that require Msh2-directed processing to allow CSR joining.

Rights and Permissions

Publisher PDF posted as allowed by the publisher's terms of use policy at: After the Initial Publication Period, RUP will grant to the public the non-exclusive right to copy, distribute, or display the Article under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 International license, as described at, or updates thereof.

DOI of Published Version



J Exp Med. 2005 Jun 20;201(12):1885-90. Epub 2005 Jun 13. Link to article on publisher's site

Journal/Book/Conference Title

The Journal of experimental medicine

Related Resources

Link to article in PubMed

PubMed ID


Creative Commons License

Creative Commons Attribution-Noncommercial 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.